Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Ligand Pharmaceuticals | LGND | Sep 24, 2024 | 99.54 | -0.12 |
Light & Wonder | LNW | Sep 24, 2024 | 90.71 | -19.50 |
Lightbridge | LTBR | Sep 24, 2024 | 2.66 | -2.92 |
LightInTheBox Holding ADR | LITB | Sep 24, 2024 | 2.81 | -4.75 |
LightPath Technologies A | LPTH | Sep 24, 2024 | 1.27 | +4.96 |
Lightspeed Commerce | LSPD | Sep 24, 2024 | 13.89 | +1.83 |
Lightwave Logic | LWLG | Sep 24, 2024 | 3.02 | +6.34 |
Lilium N.V. A | LILM | Sep 24, 2024 | 0.74 | +2.54 |
Limbach | LMB | Sep 24, 2024 | 73.83 | -3.25 |
Limoneira | LMNR | Sep 24, 2024 | 27.14 | -0.77 |
Lincoln Educational Services | LINC | Sep 24, 2024 | 12.10 | -1.63 |
Lincoln Electric | LECO | Sep 24, 2024 | 189.79 | +1.34 |
Lincoln National | LNC | Sep 24, 2024 | 31.29 | -2.28 |
Lincoln National Pref | LNC-D | Sep 24, 2024 | 28.40 | -0.32 |
Lindblad Expeditions | LIND | Sep 24, 2024 | 10.56 | +0.48 |
Linde | LIN | Sep 24, 2024 | 479.35 | +0.42 |
Lindsay | LNN | Sep 24, 2024 | 124.08 | +0.21 |
Lineage | LINE | Sep 24, 2024 | 79.78 | 0.00 |
Lineage Cell Therapeutics | LCTX | Sep 24, 2024 | 0.89 | -5.18 |
Linkage Global | LGCB | Sep 24, 2024 | 0.42 | -5.05 |
Linkbancorp | LNKB | Sep 24, 2024 | 6.51 | +0.31 |
Lion ADR | LGHL | Sep 24, 2024 | 0.23 | -1.83 |
Lion Electric | LEV | Sep 24, 2024 | 0.73 | +1.34 |
Lionheart Units | CUBWU | Sep 24, 2024 | 10.04 | 0.00 |
Lions Gate Entertainment A | LGF-A | Sep 24, 2024 | 7.69 | +1.05 |
Lions Gate Entertainment B | LGF-B | Sep 24, 2024 | 6.78 | +0.44 |
Lipella Pharmaceuticals | LIPO | Sep 24, 2024 | 0.45 | +10.32 |
Lipocine | LPCN | Sep 24, 2024 | 4.55 | +0.22 |
LiqTech International | LIQT | Sep 24, 2024 | 3.14 | 0.00 |
Liquidia | LQDA | Sep 24, 2024 | 10.12 | +1.91 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.